Patents by Inventor Gaurav TYAGI

Gaurav TYAGI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMBINATION OF A THERAPEUTIC OLIGONUCLEOTIDE TARGETING HBV AND A TLR7 AGONIST FOR TREATMENT OF HBV
    Publication number: 20230119360
    Abstract: The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a therapeutic oligonucleotide targeting HBV and a TLR7 agonist for use in the treatment of a chronic hepatitis B patient.
    Type: Application
    Filed: June 17, 2022
    Publication date: April 20, 2023
    Inventors: Lu GAO, Yonghong ZHU, Søren OTTOSEN, Henrik MUELLER, Xue ZHOU, Julie Elisabeth Françoise BLAISING, Yuyan JIN, Qingyan BO, Gaurav TYAGI
  • METHOD OF TREATING VIRUS INFECTION USING A TLR7 AGONIST
    Publication number: 20230044958
    Abstract: The present invention relates to methods of treating HBV, COVID-19 or SARS-CoV-2 infection in a human patient, wherein the methods comprise administration of a therapeutically effective amount of a TLR7 agonist, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 22, 2020
    Publication date: February 9, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Qingyan BO, Yuyan JIN, Gaurav TYAGI, Yonghong ZHU